Skip to main content

Prescription medicine

Vyjuvek

Vyjuvek is a prescription medicine. No generic is listed in FDA's NDC Directory.

  • No generic listed

Check it at the source: the vyjuvek FDA label on DailyMed (effective September 29, 2025); every vyjuvek label on DailyMed.

Highlights of the record

FDA label of September 29, 2025; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026

Used for

From the label: indications and usage

VYJUVEK is indicated for the treatment of wounds in adult and pediatric patients with dystrophic epidermolysis bullosa (DEB) with mutation(s) in the collagen type VII alpha 1 chain (COL7A1) gene.

Forms and strengths

Kit.

On the market

Generic approvals
No generic approved
Labelers listed (NDC)
1 of which 0 under generic applications, 1 under brand applications, repackagers included

Supply and safety

Pharmacy cost (NADAC)
Not in the survey
Shortage (FDA)
No current entry
Recalls by its makers (FDA)
No recall recorded
FAERS reports
129 through July 30, 2026

What is vyjuvek used for?

From the label: indications and usage

VYJUVEK is indicated for the treatment of wounds in adult and pediatric patients with dystrophic epidermolysis bullosa (DEB) with mutation(s) in the collagen type VII alpha 1 chain (COL7A1) gene. VYJUVEK is a herpes-simplex virus type 1 (HSV-1) vector-based gene therapy indicated for the treatment of wounds in adult and pediatric patients with dystrophic epidermolysis bullosa (DEB) with mutation(s) in the collagen type VII alpha 1 chain (COL7A1) gene.

Source: FDA drug label (VYJUVEK), Krystal Biotech, Inc., effective September 29, 2025 (SPL set fe207c8c-04b4-4fdf-87cf-6dbc7eb6e9c2), via openFDA; the full label on DailyMed

What does the patient leaflet for vyjuvek say first?

The FDA-approved Medication Guide or Patient Information that comes with the medicine, in its own words.

From the patient leaflet: What is the most important information I should know about VYJUVEK Gel?

…The VYJUVEK® biological suspension must be mixed with the gel at the pharmacy prior to use. …VYJUVEK gel should be applied by a healthcare professional (HCP) or by a patient/caregiver either at a healthcare professional setting (e.g., clinical) or a home setting.

From the patient leaflet: What should I avoid while taking VYJUVEK Gel?

…Avoid direct contact with treated wounds (e.g., touching or scratching) and dressings of treated wounds until the next dressing change following VYJUVEK gel application. …Individuals should wear protective gloves when assisting with changing wound dressings and handling the disposal of the dressings.

From the patient leaflet: How should I store VYJUVEK Gel?

…See the Instructions For Use for detailed instructions. …VYJUVEK gel syringes may remain at room temperature (20° to 25°C (68° to 77°F)) for up to 8 hours prior to application. Administration syringes can be kept in an appropriate insulated or temperature regulated secondary container for up to 48 hours at 2° to 8°C (35.6° to 46.4°F). …Follow expiration information provided by the pharmacy. If you have any questions, reach out to the pharmacy for additional information.

Source: FDA drug label (VYJUVEK), Krystal Biotech, Inc., effective September 29, 2025 (SPL set fe207c8c-04b4-4fdf-87cf-6dbc7eb6e9c2), via openFDA; the full label on DailyMed

Is there a generic for vyjuvek?

No generic vyjuvek is approved (Drugs@FDA, October 8, 2026).

Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)

What do FAERS reports show for vyjuvek?

The FDA Adverse Event Reporting System holds 129 reports that list vyjuvek among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 1 are coded as a death and 15 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.

The most reported reactions

  • Pruritus11
  • Pyrexia10
  • Wound Infection10
  • Drug Ineffective (a use or a product term, not a reaction)9
  • Wound Complication8
  • Application Site Pain7
  • Application Site Pruritus7
  • Blister7

Side effects: the label's list and every FAERS reaction

Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026

What next?

Vyjuvek side effects
the label's list beside FAERS reports
Check an interaction
what two or more labels say about each other